Ulcerative Colitis

Multicenter Study to Evaluate the Efficacy and Safety of the medication in Subjects with Moderately-to-Severely Active Ulcerative Colitis. Male and female patients ages 18 and up. Enter your information below, and someone from the Gen1 team will contact you to schedule an in-person screening

Now Enrolling in Port Jefferson Station, NY

Subscribe to our newsletter

© 2019 by GEN1 Research,LLC.

9433 Bee Caves Road

Building 3, Suite 125

Austin, TX 78733

P: 512-717-8610

F: 512-532-0689